8-K

Company

Seres Therapeutics, Inc.

Filed

July 22, 2025

Period of Report

July 17, 2025

Accession Number

0001193125-25-162552

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →